Abiopharma

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA

New Form 10-Q - Zura Bio Ltd Filed: 2025-08-14 AccNo: 0001410578-25-001783 Size: 6 MB

New Form 8-K - AMEDISYS INC Filed: 2025-08-14 AccNo: 0001104659-25-078145 Size: 354 KB Item 1.02: Termination of a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: …

New Form SCHEDULE 13G/A - Brookdale Senior Living Inc. Filed: 2025-08-14 AccNo: 0001193805-25-001189 Size: 16 KB

Biomerica, Inc. - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use

New Form 10-Q - CASSAVA SCIENCES INC Filed: 2025-08-14 AccNo: 0001437749-25-026686 Size: 5 MB

New Form 8-K - Unicycive Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0001213900-25-076066 Size: 298 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Lifeward Ltd. Filed: 2025-08-14 AccNo: 0001178913-25-002900 Size: 822 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - Zai Lab Ltd Filed: 2025-08-14 AccNo: 0001415889-25-021718 Size: 12 KB

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

New Form SCHEDULE 13G/A - Verastem, Inc. Filed: 2025-08-14 AccNo: 0001415889-25-021716 Size: 10 KB

New Form SCHEDULE 13G/A - uniQure N.V. Filed: 2025-08-14 AccNo: 0001415889-25-021714 Size: 10 KB